de-Freitas NR, Lima LB, de-Moura MB, Veloso-Guedes CCF, Simamoto-Jnior PC, de-Magalhes D. Bisphosphonate treatment and dental implants: A systematic review. Med Oral Patol Oral Cir Bucal. 2016 Sep 1;21 (5):e644-51. 

 

 

doi:10.4317/medoral.20920

http://dx.doi.org/doi:10.4317/medoral.20920

 

 

1. Drake MT, Clarke BL, Lewiecki EM. The Pathophisiology and Treatment of Osteoporosis. Clin Ther. 2015;37:1837-50.
http://dx.doi.org/10.1016/j.clinthera.2015.06.006

 

2. Madrid C, Sanz M. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review. Clin Oral Implants Res. 2009;20 Suppl 4:S87-95.
http://dx.doi.org/10.1111/j.1600-0501.2009.01772.x

 

3. Shabestari GO, Shayesteh YS, Khojasteh A, Alikhasi M, Moslemi N, Aminian A, et al. Implant Placement in Patients with Oral Bisphosphonate Therapy: A Case Series. Clin Implant Dent Relat Res. 2010;12:175-80.

 

4. Montoya-Carralero JM, Parra-Mino P, Ramrez-Fernndez P, Morata-Murcia IM, Mompen-Gabn MC, Calvo-Guirado JL. Dental implants in patients treated with oral bisphosphonates: A bibliographic review. Med Oral Patol Oral Cir Bucal. 2010;15:e65-9.

 

5. Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw-2014 update. J Oral Maxillofac Surg. 2014;72:1938-56.
http://dx.doi.org/10.1016/j.joms.2014.04.031

 

6. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61:1115-7.
http://dx.doi.org/10.1016/S0278-2391(03)00720-1

 

7. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264-9.
http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00135

 

8. Fugazzotto PA, Scott Lightfoot W, Jaffin R, Kumar A. Implant Placement With or Without Simultaneous Tooth Extraction in Patients Taking Oral Bisphosphonates: Postoperative Healing, Early Follow-Up, and the Incidence of Complications in Two Private Practices. J Periodontol. 2007;78:1664-9.
http://dx.doi.org/10.1902/jop.2007.060514

 

9. Memon S, Weltman RL, Katancik JA. Oral Bisphosphonates: Early Endosseous Dental Implant Success and Crestal Bone Changes. A Retrospective Study. Int J Oral Maxillofac Implants. 2012;27:1216-22.

 

10. Koka S, Suresh Babu NM, Norell A. Survival of dental implants in post-menopausal bisphosphonate users. J Prosthodont Res. 2010;54:108-11.
http://dx.doi.org/10.1016/j.jpor.2010.04.002

 

11. Kwon TG, Lee CO, Park JW, Choi SY, Rijal G, Shin HI. Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment. Clin. Oral Implants Res. 2014;25:632-40.
http://dx.doi.org/10.1111/clr.12088

 

12. Zahid TM, Wang BY, Cohen RE. Influence of Bisphosphonates on Alveolar Bone Loss Around Osseointegrated Implants. J Oral Implantol. 2011;37:335-46.
http://dx.doi.org/10.1563/AAID-JOI-D-09-00114

 

13. Bell BM, Bell RE. Oral Bisphosphonates and Dental Implants: A Retrospective Study. J Oral Maxillofac Surg. 2008;66:1022-4.
http://dx.doi.org/10.1016/j.joms.2007.12.040

 

14. Grant BT, Amenedo C, Freeman K, Kraut RA. Outcomes of Placing Dental Implants in Patients Taking Oral Bisphosphonates: A Review of 115 Cases. J Oral Maxillofac Surg. 2008;66:223-30.
http://dx.doi.org/10.1016/j.joms.2007.09.019

 

15. Jacobsen C, Metzler P, Rssle M, Obwegeser J, Zemann W, Grtz KW. Osteopathology induced by bisphosphonates and dental implants: clinical observations. Clin Oral Investig. 2013;17:167-75.
http://dx.doi.org/10.1007/s00784-012-0708-2

 

16. Siebert T, Jurkovic R, Statelova D, Strecha J. Immediate implant placement in a patient with osteoporis undergoing bisphosphonate therapy: 1-year preliminary prospective study. J Oral Implantol. 2015;41:360-5.
http://dx.doi.org/10.1563/AAID-JOI-D-13-00063

 

17. Martin DC, O'Ryan FS, Indresano AT, Bogdanos P, Wang B, Hui RL, et al. Characteristics of Implant Failures in Patients With a History of Oral Bisphosphonate Therapy. J Oral Maxillofac Surg. 2010;68:508-14.
http://dx.doi.org/10.1016/j.joms.2009.09.055

 

18. Lpez-Cedrn JL , Sanromn JF , Garca A, Pe-arrocha M , Feijoo JF , Limeres J, et al. Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series. Br J Oral Maxillofac Surg. 2013;51:874-9.
http://dx.doi.org/10.1016/j.bjoms.2013.06.011

 

19. Lazarovici TS, Yahalom R, Taicher S, Schwartz-Arad D, Peleg O, Yarom N. Bisphosphonate Related Osteonecrosis of the Jaw Associated With Dental Implants. J Oral Maxillofac Surg. 2010;68:790-6.
http://dx.doi.org/10.1016/j.joms.2009.09.017

 

20. Goss A, Mark Bartold M, Sambrook P, Peter Hawker P. The Nature and Frequency of Bisphosphonate-Associated Osteonecrosis of the Jaws in Dental Implant Patients: A South Australian Case Series. J Oral Maxillofac Surg. 2010;68:337-43.
http://dx.doi.org/10.1016/j.joms.2009.09.037

 

21. Tam Y, Kar K, Nowzari H, Cha HS, Ahn KM. Osteonecrosis of the Jaw after Implant Surgery in Patients Treated with Bisphosphonates - A Presentation of Six Consecutive Cases. Clin Implant Dent Relat Res. 2014;16:751-61.
http://dx.doi.org/10.1111/cid.12048

 

22. Durieux N, Vandenput S, Pasleau F. [OCEBM levels of evidence system]. Rev Med Liege. 2013;68:644-9.

 

23. Holzinger D, Seemann R, Matoni N, Ewers R, Millesi W, Wutzl A. Effect of Dental Implants on Bisphosphonate-Related Osteonecrosis of the Jaws. J Oral Maxillofac Surg. 2014;72:e1.1937-8.

 

24. Javed F, Almas K. Osseointegration of Dental Implants in Patients Undergoing Bisphosphonate Treatment: A Literature Review. J Periodontol. 2010;81:479-84.
http://dx.doi.org/10.1902/jop.2009.090587

 

25. Serra MP, Llorca CS, Donat FJ. Oral implants in patients receiving bisphosphonates: a review and update. Med Oral Patol Oral Cir Bucal. 2008;13:E755-60.

 

26. Ata-Ali J, Ata-Ali F, Pe-arrocha-Oltra D, Galindo-Moreno P. What is the impact of bisphosphonate therapy upon dental implant survival?. A systematic review and meta-analysis. Clin Oral Implants Res. 2016;27:e38-46.
http://dx.doi.org/10.1111/clr.12526

 

27. Yip JK, Borrell LN, Cho SC, Francisco H, Tarnow DP. Association between oral bisphosphonate use and dental implant failure among middle-aged women. J Clin Periodontol. 2012;39:408-14.
http://dx.doi.org/10.1111/j.1600-051X.2012.01854.x

 

28. Marx RE, Cillo JE Jr, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg. 2007;65:2397-410.
http://dx.doi.org/10.1016/j.joms.2007.08.003

 

29. Ruhin B. Implants and biphosphonates: 2012 guidelines for practitioners. Rev Stomatol Chir Maxillofac Chir Orale. 2013;114:1-3.
http://dx.doi.org/10.1016/j.revsto.2012.12.009

 

30. Otomo-Corgel J. Osteoporosis and Osteopenia: Implications for periodontal and implant therapy. Periodontology 2000. 2012;59:111-39.
http://dx.doi.org/10.1111/j.1600-0757.2011.00435.x